Skip to main content
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.700
-0.060 (-3.41%)
At close: Apr 28, 2026, 4:00 PM EDT
1.700
0.00 (0.00%)
Pre-market: Apr 29, 2026, 7:00 AM EDT

Pyxis Oncology Revenue

In the year 2025, Pyxis Oncology had annual revenue of $13.86M, down -14.17%. Pyxis Oncology had revenue of $11.04M in the quarter ending December 31, 2025.

Revenue (ttm)
$13.86M
Revenue Growth
-14.17%
P/S Ratio
7.71
Revenue / Employee
$247,464
Employees
56
Market Cap
106.81M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202513.86M-2.29M-14.17%
Dec 31, 202416.15M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Verrica Pharmaceuticals 35.58M
Innate Pharma 10.57M
Cibus 3.64M
Cardiff Oncology 593.00K
NeOnc Technologies Holdings 39.99K
Revenue Rankings

PYXS News

More News